BRAF (V600E) mutation in isthmic malignant thyroid nodules

被引：3
|
作者：
Campenni, A. [1 ]
Giovanella, L. [2 ,3 ]
Alibrandi, A. [4 ]
Siracusa, M. [1 ]
Ruggeri, R. M. [5 ]
Baldari, S. [1 ]
机构：
[1] Univ Messina, Nucl Med Unit, Dept Biomed Sci & Morphol & Funct Images, Messina, Italy
[2] Oncol Inst So Switzerland, Nucl Med, Bellinzona, Switzerland
[3] Oncol Inst So Switzerland, PET CT Ctr, Bellinzona, Switzerland
[4] Univ Messina, Dept Econ Business & Environm Sci & Quantitat Met, Messina, Italy
[5] Univ Messina, Dept Clin & Expt Med & Pharmacol, Endocrinol Sect, Messina, Italy
来源：
CLINICAL ENDOCRINOLOGY | 2016年 / 84卷 / 01期
关键词：
RISK; ABLATION; CANCER;
D O I：
10.1111/cen.12858
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：152 / 153
页数：3
相关论文
共 50 条
  • [41] Evaluation of TERT Promoter and BRAF (V600E) Mutation Analysis on LBC-processed Thyroid Malignant Lesions
    Dell'Aquila, Marco
    Martini, Maurizio
    Fiorentino, Vincenzo
    Musarra, Teresa
    Zhang, Qianqian
    Brunelli, Chiara
    Fadda, Guido
    Larocca, Luigi Maria
    Rossi, Esther
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 341 - 341
  • [42] Evaluation of TERT Promoter and BRAF (V600E) Mutation Analysis on LBC-processed Thyroid Malignant Lesions
    Dell'Aquila, Marco
    Martini, Maurizio
    Fiorentino, Vincenzo
    Musarra, Teresa
    Zhang, Qianqian
    Brunelli, Chiara
    Fadda, Guido
    Larocca, Luigi Maria
    Rossi, Esther
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 341 - 341
  • [43] Preoperative BRAF( V600E) Mutation Screening Is Unlikely to Alter Initial Surgical Treatment of Patients With Indeterminate Thyroid Nodules
    Lodewijk, Lutske
    Kist, Jakob W.
    Valk, Gerlof D.
    Vriens, Menno R.
    Rinkes, Inne H. M. Borel
    CANCER, 2014, 120 (07) : 1083 - 1084
  • [44] Association between the BRAF V600E mutation and ultrasound features of the thyroid in thyroid papillary carcinoma
    Li, Qian
    Yuan, Jianjun
    Wang, Yan
    Zhai, Yuanpeng
    ONCOLOGY LETTERS, 2017, 14 (02) : 1439 - 1444
  • [45] BRAF V600E Mutations in Infarcted Thyroid Carcinoma
    Kouba, Erik
    Ford, Andrew
    Brown, Charmaine G.
    Yeh, Chen
    Kim, Hyung-Gyoon
    Siegal, Gene P.
    Manne, Upender
    Eltoum, Isam-Eldin
    LABORATORY INVESTIGATION, 2017, 97 : 327A - 327A
  • [46] Cerebellar Pleomorphic Xanthoastrocytoma with BRAF V600E Mutation
    Kim, Sang Ho
    Hwang, Kihwan
    Lee, Kyu Sang
    Choe, Gheeyoung
    Kim, Chae-Yong
    WORLD NEUROSURGERY, 2020, 139 : 577 - 581
  • [47] Targeting the BRAF V600E Mutation in Multiple Myeloma
    Andrulis, Mindaugas
    Lehners, Nicola
    Capper, David
    Penzel, Roland
    Heining, Christoph
    Huellein, Jennifer
    Zenz, Thorsten
    von Deimling, Andreas
    Schirmacher, Peter
    Ho, Anthony D.
    Goldschmidt, Hartmut
    Neben, Kai
    Raab, Marc S.
    CANCER DISCOVERY, 2013, 3 (08) : 862 - 869
  • [48] BRAF V600E in Pediatric Papillary Thyroid Carcinomas
    Paulson, V. A.
    Hollowell, M. L.
    Huang, S. A.
    Barletta, J. A.
    LABORATORY INVESTIGATION, 2014, 94 : 157A - 157A
  • [49] Sequencing Therapies in a Patient With the BRAF V600E Mutation
    Bekaii-Saab, Tanios S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (11)
  • [50] Immunohistochemical analysis of BRAF V600E mutation in ameloblastomas
    Alan Motta do Canto
    Barbara Michaela Reis da Silva Marcelino
    Juliana Lucena Schussel
    Bruna F. Wastner
    Laurindo Moacir Sassi
    Luciana Corrêa
    Ronaldo Rodrigues de Freitas
    Bengt Hasséus
    Göran Kjeller
    Celso Augusto Lemos Junior
    Paulo Henrique Braz-Silva
    Clinical Oral Investigations, 2019, 23 : 779 - 784
12345